{"id":"dipyrocetyl","rwe":[],"tags":[{"label":"dipyrocetyl","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"M01BA02","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pyrocat","offLabel":[],"synonyms":["dipyrocetyl","artromialgina","movirene","pyrocat"],"timeline":[],"approvals":[],"brandName":"Pyrocat","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"dipyrocetyl","explanation":"Imagine your body's cells are like locks, and Pyrocat is a key that fits into one of those locks. When it binds to the lock, it triggers a series of chemical reactions that help to treat a particular condition. This process is called a pharmacological response.","oneSentence":"Pyrocat works by interacting with a specific molecular target to produce its therapeutic effect.","technicalDetail":"Pyrocat is a dipyrocetyl, a class of small molecule compounds that exert their effects through a complex interplay of molecular interactions, including binding to specific receptors and influencing downstream signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3160","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DIPYROCETYL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:42:18.733333","biosimilars":[],"competitors":[{"drugName":"phenylbutazone","drugSlug":"phenylbutazone","fdaApproval":"1980-01-10","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"acetylsalicylic acid","drugSlug":"acetylsalicylic-acid","fdaApproval":"1950-04-12","relationship":"same-class"}],"genericName":"dipyrocetyl","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"phenylbutazone","brandName":"phenylbutazone","genericName":"phenylbutazone","approvalYear":"1980","relationship":"same-class"},{"drugId":"acetylsalicylic-acid","brandName":"acetylsalicylic acid","genericName":"acetylsalicylic acid","approvalYear":"1950","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"EF5UVE254C","CHEBI":"CHEBI:107635","INN_ID":"645","UMLSCUI":"C2825247","ChEMBL_ID":"CHEMBL1451173","KEGG_DRUG":"D07290","DRUGBANK_ID":"DB13839","PUBCHEM_CID":"68093"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"M01BA02","allCodes":["M01BA02","N02BA09","N02BA59","N02BA79"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pyrocat, also known as dipyrocetyl, is a small molecule drug of unknown target and class. Its commercial status is unclear, and it is not known whether it is FDA-approved or off-patent. The indications for Pyrocat are also unknown. As a result, there is limited information available on its safety profile and pharmacokinetics. Further research is needed to fully understand this compound.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}